Anna G. Ramazanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna G. Ramazanova has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- German L. Perlovich
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia
8 shared publications - Alexander P. Voronin
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia
6 shared publications - Andrei V. Churakov
N.S. Kurnakov Institute of General and Inorganic Chemistry RAS Moscow Russia
6 shared publications - Victor V. Korolev
Structure and dynamics of molecular and ion-molecular solutions, Physical chemistry of polymer-liquid heterogeneous systems, G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo, Russia
5 shared publications - Anna Vladimirovna Vologzhanina
Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences, 28-1 Vavilova st., 119334 Moscow, Russia
4 shared publications - Ksenia V. Drozd
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russian Federation
4 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1422
Pharmaceutical Salts vs. Ionic Cocrystals: A Combined Structural and Solubility Study of Fluoxetine Multicomponent Crystals
Background/Objectives: The present work constitutes the comparative study of solubility and dissolution parameters of pharmaceutical salts and ionic cocrystals using the ternary system (fluoxetine:hydrochloric acid:fumaric acid) as an example. Methods: A multi-stage synthesis based on extraction of fluoxetine (FXT) free base into the diethyl ether layer was used to isolate two stable fumaric acid (FumAc) salts with (1:1) and (2:1) stoichiometry and a metastable polymorph of the (1:1) salt. The solvent-dependent solubility of FXT∙HCl, [FXT+FumAc] (1:1) salt and [FXT∙HCl+FumAc] (2:1) ionic cocrystal was rationalized in terms of acid–base equilibria, common ion effect, activity coefficients and surfactant-like activity of FXT supported by crystal packing analysis. Different kinetic models were applied to fit the experimental dissolution profiles in blank and supplemented biorelevant FaSSGF and FaSSIF media. Results: The crystal structure of fluoxetine hydrogen fumarate was found to feature the robust layered packing involving 2D hydrogen-bonded sheets separated by FXTH+ bilayers. The highest solubility advantage with respect to commercial FXT∙HCl in acidic media (4.8 times) was confirmed for [FXT+FumAc] (1:1) in pH 1.2 buffer solution, while the [FXT∙HCl+FumAc] (2:1) ionic cocrystal demonstrates the highest solubility (1.9 times) in blank FaSSIF medium (pH 6.5). The dissolution kinetic of studied solid forms was best modeled by zero-order and Korsmeyer–Peppas models. Conclusions: The solubility and dissolution rate were established to be inversely dependent on the solid form stability in specific media. The ionic cocrystal was observed to be the only solid form to demonstrate improved dissolution rate in complemented FaSSGF due to the un-ionized state of fumaric acid resulting in formation of mixed micelles with solubilizers. The [FXT+FumAc] (1:1) salt and the [FXT∙HCl+FumAc] ionic cocrystal can be recommended as soluble solid forms of fluoxetine, respectively, for gastro-soluble and enteric-coated formulations.
- 3 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1422
Open AccessPharmaceutical Salts vs. Ionic Cocrystals: A Combined Structural and Solubility Study of Fluoxetine Multicomponent Crystals
Background/Objectives: The present work constitutes the comparative study of solubility and dissolution parameters of pharmaceutical salts and ionic cocrystals using the ternary system (fluoxetine:hydrochloric acid:fumaric acid) as an example. Methods: A multi-stage synthesis based on extraction of fluoxetine (FXT) free base into the diethyl ether layer was used to isolate two stable fumaric acid (FumAc) salts with (1:1) and (2:1) stoichiometry and a metastable polymorph of the (1:1) salt. The solvent-dependent solubility of FXT∙HCl, [FXT+FumAc] (1:1) salt and [FXT∙HCl+FumAc] (2:1) ionic cocrystal was rationalized in terms of acid–base equilibria, common ion effect, activity coefficients and surfactant-like activity of FXT supported by crystal packing analysis. Different kinetic models were applied to fit the experimental dissolution profiles in blank and supplemented biorelevant FaSSGF and FaSSIF media. Results: The crystal structure of fluoxetine hydrogen fumarate was found to feature the robust layered packing involving 2D hydrogen-bonded sheets separated by FXTH+ bilayers. The highest solubility advantage with respect to commercial FXT∙HCl in acidic media (4.8 times) was confirmed for [FXT+FumAc] (1:1) in pH 1.2 buffer solution, while the [FXT∙HCl+FumAc] (2:1) ionic cocrystal demonstrates the highest solubility (1.9 times) in blank FaSSIF medium (pH 6.5). The dissolution kinetic of studied solid forms was best modeled by zero-order and Korsmeyer–Peppas models. Conclusions: The solubility and dissolution rate were established to be inversely dependent on the solid form stability in specific media. The ionic cocrystal was observed to be the only solid form to demonstrate improved dissolution rate in complemented FaSSGF due to the un-ionized state of fumaric acid resulting in formation of mixed micelles with solubilizers. The [FXT+FumAc] (1:1) salt and the [FXT∙HCl+FumAc] ionic cocrystal can be recommended as soluble solid forms of fluoxetine, respectively, for gastro-soluble and enteric-coated formulations.
- 19 May 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (11) , 4184-4197
Structural Diversity of Iproniazid Multicomponent Crystals with Isomeric Dihydroxybenzoic Acids: Implications for Solid-State Properties
- 19 May 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (11) , 4184-4197
Structural Diversity of Iproniazid Multicomponent Crystals with Isomeric Dihydroxybenzoic Acids: Implications for Solid-State Properties
- 9 December 2025
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (1) , 235-251
Trimorphism in riluzole salicylate: screening, crystal structures and solution thermodynamics
Purpose This study investigated the phenomenon of polymorphism in the pharmaceutical salt riluzole salicylate with the aim to modify the aqueous solubility and dissolution rate of riluzole. Methods Preparation routes and transformation pathways were investigated using mechanoactivation, sonication, sublimation and melt crystallization. The thermal-induced phase transformations were interpreted by thermal microscopy and ex situ PXRD analysis. The crystal structure of Form 3 was solved from powder diffraction data. The differences in non-covalent interactions in crystals of Form 1 and Form 3 and their role in structure stabilization were studied by QTAIMC analysis, fingerprint plots, energy frameworks and lattice energy calculations. Cocrystallization thermodynamic functions and relationships between three polymorphs were established based on DSC, solubility and lattice energy data. Results Two novel polymorphs of riluzole salicylate with higher melting points were discovered and characterized in addition to reported Form 1. The stable Form 3 can be obtained easily by milling or from the slurry, while the metastable Form 2 forms only by melt crystallization or resublimation. Form 3 has stronger hydrogen bonding and more balanced non-covalent interactions than Form 1, making it thermodynamically favored at room temperature, while Form 1 is more stable near absolute zero. Conclusion Polymorphism significantly affects the pharmaceutical properties of riluzole salicylate. Selective preparation of polymorphs enables tuning of solubility and dissolution, linking crystal structure and thermodynamics to drug delivery optimization. Slower release kinetics of Form 1 compared to Form 3 and parent RLZ indicates its potential use as a prolonged form.
- 9 December 2025
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (1) , 235-251
Trimorphism in riluzole salicylate: screening, crystal structures and solution thermodynamics
Purpose This study investigated the phenomenon of polymorphism in the pharmaceutical salt riluzole salicylate with the aim to modify the aqueous solubility and dissolution rate of riluzole. Methods Preparation routes and transformation pathways were investigated using mechanoactivation, sonication, sublimation and melt crystallization. The thermal-induced phase transformations were interpreted by thermal microscopy and ex situ PXRD analysis. The crystal structure of Form 3 was solved from powder diffraction data. The differences in non-covalent interactions in crystals of Form 1 and Form 3 and their role in structure stabilization were studied by QTAIMC analysis, fingerprint plots, energy frameworks and lattice energy calculations. Cocrystallization thermodynamic functions and relationships between three polymorphs were established based on DSC, solubility and lattice energy data. Results Two novel polymorphs of riluzole salicylate with higher melting points were discovered and characterized in addition to reported Form 1. The stable Form 3 can be obtained easily by milling or from the slurry, while the metastable Form 2 forms only by melt crystallization or resublimation. Form 3 has stronger hydrogen bonding and more balanced non-covalent interactions than Form 1, making it thermodynamically favored at room temperature, while Form 1 is more stable near absolute zero. Conclusion Polymorphism significantly affects the pharmaceutical properties of riluzole salicylate. Selective preparation of polymorphs enables tuning of solubility and dissolution, linking crystal structure and thermodynamics to drug delivery optimization. Slower release kinetics of Form 1 compared to Form 3 and parent RLZ indicates its potential use as a prolonged form.
- 12 August 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (17) , 7243-7263
Hydrogen Bond Architecture, Thermal Anisotropy, and Dissolution Performance of Riluzole Multicomponent Crystals
- 12 August 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (17) , 7243-7263
Hydrogen Bond Architecture, Thermal Anisotropy, and Dissolution Performance of Riluzole Multicomponent Crystals
- 30 October 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (22) , 9773-9789
Virtual Screening, Polymorphism, and Formation Thermodynamics Study of Riluzole Multicomponent Crystals with Dihydroxybenzoic Acids
- 30 October 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (22) , 9773-9789
Virtual Screening, Polymorphism, and Formation Thermodynamics Study of Riluzole Multicomponent Crystals with Dihydroxybenzoic Acids
- 1 December 2023
- Published by Pleiades Publishing Ltd in Nanobiotechnology Reports
- Vol. 18 (6) , 894-901
On the Physical–Chemical and Magnetic–Thermal Properties of Magnetite Magnetic Fluids with the Addition of Graphene
In this work, the synthesis of a magnetite/graphene composite and a magnetic fluid based on it is carried out. The physical–chemical and magnetic–thermal properties of the obtained samples are studied. It is established that in the magnetite/graphene composite magnetite nanoparticles are adsorbed on the graphene surface in the form of aggregates. It is found that the specific surface area and pore volume of the magnetite/graphene composite are higher than the values for magnetite. Analysis of the rheological curves of the magnetic fluid characterizes its structure as homogeneous and indicates a uniform distribution of the dispersed phase in the dispersion medium. It is established that the magnetic fluid with the composite is thermally stable up to 210°С. The values of the specific heat capacity of the synthesized sample are slightly higher than the heat capacity of the liquid without graphene additives. It is noted that the addition of an insignificant part of graphene to the magnetic phase of the magnetic fluid leads to a twofold increase in the value of the magnetocaloric effect (MCE) and changes the shape of the temperature dependence of the MCE in the studied temperature range.
- 1 December 2023
- Published by Pleiades Publishing Ltd in Nanobiotechnology Reports
- Vol. 18 (6) , 894-901
On the Physical–Chemical and Magnetic–Thermal Properties of Magnetite Magnetic Fluids with the Addition of Graphene
In this work, the synthesis of a magnetite/graphene composite and a magnetic fluid based on it is carried out. The physical–chemical and magnetic–thermal properties of the obtained samples are studied. It is established that in the magnetite/graphene composite magnetite nanoparticles are adsorbed on the graphene surface in the form of aggregates. It is found that the specific surface area and pore volume of the magnetite/graphene composite are higher than the values for magnetite. Analysis of the rheological curves of the magnetic fluid characterizes its structure as homogeneous and indicates a uniform distribution of the dispersed phase in the dispersion medium. It is established that the magnetic fluid with the composite is thermally stable up to 210°С. The values of the specific heat capacity of the synthesized sample are slightly higher than the heat capacity of the liquid without graphene additives. It is noted that the addition of an insignificant part of graphene to the magnetic phase of the magnetic fluid leads to a twofold increase in the value of the magnetocaloric effect (MCE) and changes the shape of the temperature dependence of the MCE in the studied temperature range.
- 14 August 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (9) , 6926-6943
Multicomponent Crystals of Amitriptyline as Potential Controlled-Release Systems: Synthesis, Crystal Packing Analysis, and Dissolution Study
- 14 August 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (9) , 6926-6943
Multicomponent Crystals of Amitriptyline as Potential Controlled-Release Systems: Synthesis, Crystal Packing Analysis, and Dissolution Study
- Open Access
- 15 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (6) , 1747
Polymorphism of Carbamazepine Pharmaceutical Cocrystal: Structural Analysis and Solubility Performance
Polymorphism is a common phenomenon among single- and multicomponent molecular crystals that has a significant impact on the contemporary drug development process. A new polymorphic form of the drug carbamazepine (CBZ) cocrystal with methylparaben (MePRB) in a 1:1 molar ratio as well as the drug’s channel-like cocrystal containing highly disordered coformer molecules have been obtained and characterized in this work using various analytical methods, including thermal analysis, Raman spectroscopy, and single-crystal and high-resolution synchrotron powder X-ray diffraction. Structural analysis of the solid forms revealed a close resemblance between novel form II and previously reported form I of the [CBZ + MePRB] (1:1) cocrystal in terms of hydrogen bond networks and overall packing arrangements. The channel-like cocrystal was found to belong to a distinct family of isostructural CBZ cocrystals with coformers of similar size and shape. Form I and form II of the 1:1 cocrystal appeared to be related by a monotropic relationship, with form II being proven to be the thermodynamically more stable phase. The dissolution performance of both polymorphs in aqueous media was significantly enhanced when compared with parent CBZ. However, considering the superior thermodynamic stability and consistent dissolution profile, the discovered form II of the [CBZ + MePRB] (1:1) cocrystal seems a more promising and reliable solid form for further pharmaceutical development.
- 15 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (6) , 1747
Open AccessPolymorphism of Carbamazepine Pharmaceutical Cocrystal: Structural Analysis and Solubility Performance
Polymorphism is a common phenomenon among single- and multicomponent molecular crystals that has a significant impact on the contemporary drug development process. A new polymorphic form of the drug carbamazepine (CBZ) cocrystal with methylparaben (MePRB) in a 1:1 molar ratio as well as the drug’s channel-like cocrystal containing highly disordered coformer molecules have been obtained and characterized in this work using various analytical methods, including thermal analysis, Raman spectroscopy, and single-crystal and high-resolution synchrotron powder X-ray diffraction. Structural analysis of the solid forms revealed a close resemblance between novel form II and previously reported form I of the [CBZ + MePRB] (1:1) cocrystal in terms of hydrogen bond networks and overall packing arrangements. The channel-like cocrystal was found to belong to a distinct family of isostructural CBZ cocrystals with coformers of similar size and shape. Form I and form II of the 1:1 cocrystal appeared to be related by a monotropic relationship, with form II being proven to be the thermodynamically more stable phase. The dissolution performance of both polymorphs in aqueous media was significantly enhanced when compared with parent CBZ. However, considering the superior thermodynamic stability and consistent dissolution profile, the discovered form II of the [CBZ + MePRB] (1:1) cocrystal seems a more promising and reliable solid form for further pharmaceutical development.
- Open Access
- 3 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 836
Virtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals
In this study, the existing set of carbamazepine (CBZ) cocrystals was extended through the successful combination of the drug with the positional isomers of acetamidobenzoic acid. The structural and energetic features of the CBZ cocrystals with 3- and 4-acetamidobenzoic acids were elucidated via single-crystal X-ray diffraction followed by QTAIMC analysis. The ability of three fundamentally different virtual screening methods to predict the correct cocrystallization outcome for CBZ was assessed based on the new experimental results obtained in this study and data available in the literature. It was found that the hydrogen bond propensity model performed the worst in distinguishing positive and negative results of CBZ cocrystallization experiments with 87 coformers, attaining an accuracy value lower than random guessing. The method that utilizes molecular electrostatic potential maps and the machine learning approach named CCGNet exhibited comparable results in terms of prediction metrics, albeit the latter resulted in superior specificity and overall accuracy while requiring no time-consuming DFT computations. In addition, formation thermodynamic parameters for the newly obtained CBZ cocrystals with 3- and 4-acetamidobenzoic acids were evaluated using temperature dependences of the cocrystallization Gibbs energy. The cocrystallization reactions between CBZ and the selected coformers were found to be enthalpy-driven, with entropy terms being statistically different from zero. The observed difference in dissolution behavior of the cocrystals in aqueous media was thought to be caused by variations in their thermodynamic stability.
- 3 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 836
Open AccessVirtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals
In this study, the existing set of carbamazepine (CBZ) cocrystals was extended through the successful combination of the drug with the positional isomers of acetamidobenzoic acid. The structural and energetic features of the CBZ cocrystals with 3- and 4-acetamidobenzoic acids were elucidated via single-crystal X-ray diffraction followed by QTAIMC analysis. The ability of three fundamentally different virtual screening methods to predict the correct cocrystallization outcome for CBZ was assessed based on the new experimental results obtained in this study and data available in the literature. It was found that the hydrogen bond propensity model performed the worst in distinguishing positive and negative results of CBZ cocrystallization experiments with 87 coformers, attaining an accuracy value lower than random guessing. The method that utilizes molecular electrostatic potential maps and the machine learning approach named CCGNet exhibited comparable results in terms of prediction metrics, albeit the latter resulted in superior specificity and overall accuracy while requiring no time-consuming DFT computations. In addition, formation thermodynamic parameters for the newly obtained CBZ cocrystals with 3- and 4-acetamidobenzoic acids were evaluated using temperature dependences of the cocrystallization Gibbs energy. The cocrystallization reactions between CBZ and the selected coformers were found to be enthalpy-driven, with entropy terms being statistically different from zero. The observed difference in dissolution behavior of the cocrystals in aqueous media was thought to be caused by variations in their thermodynamic stability.
- Open Access
- 11 January 2023
- Published by Industrial University of Tyumen in Oil and Gas Studies
- No. 6,p. 94-109
Oil-based magnetic fluids. Synthesis, properties, and application prospects
В данной работе были синтезированы и исследованы магнетитовые магнитные жидкости на основе нефти. Определены их физико-химические параметры (плотность, вязкость, размер частиц магнитной фазы). Проведен ИК-спектроскопический и термогравиметрический анализ. Микрокалориметрическим методом определены магнитокалорические свойства (магнитокалорический эффект и теплоемкость) магнитных жидкостей в интервале температур 278–350 К при изменении магнитного поля от 0 до 1,0 Тл. Максимальное значение магнитокалорического эффекта магнитной жидкости с объемной концентрацией магнитной фазы 0,08 составляет 0,0035 К при 310 К и магнитной индукции 1,0 Тл. Полученные образцы магнитных жидкостей имеют низкую себестоимость по сравнению с устойчивыми магнитными жидкостями на основе полиэтилсилоксанов и алкаренов, так как в качестве жидкости-носителя используется нефть.
- 11 January 2023
- Published by Industrial University of Tyumen in Oil and Gas Studies
- No. 6,p. 94-109
Open AccessOil-based magnetic fluids. Synthesis, properties, and application prospects
В данной работе были синтезированы и исследованы магнетитовые магнитные жидкости на основе нефти. Определены их физико-химические параметры (плотность, вязкость, размер частиц магнитной фазы). Проведен ИК-спектроскопический и термогравиметрический анализ. Микрокалориметрическим методом определены магнитокалорические свойства (магнитокалорический эффект и теплоемкость) магнитных жидкостей в интервале температур 278–350 К при изменении магнитного поля от 0 до 1,0 Тл. Максимальное значение магнитокалорического эффекта магнитной жидкости с объемной концентрацией магнитной фазы 0,08 составляет 0,0035 К при 310 К и магнитной индукции 1,0 Тл. Полученные образцы магнитных жидкостей имеют низкую себестоимость по сравнению с устойчивыми магнитными жидкостями на основе полиэтилсилоксанов и алкаренов, так как в качестве жидкости-носителя используется нефть.